Biological indicators of genotoxic risk and metabolic polymorphisms

Mutation Research - Reviews in Mutation Research

Volumn 463, Issue 3, 2000, Pages 285-308

  Pavanello, Sofia ^a   Clonfero, Erminio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLTRANSFERASE; ALDEHYDE DEHYDROGENASE; ARYLDIALKYLPHOSPHATASE; CYTOCHROME P450; DEBRISOQUINE 4 HYDROXYLASE; DIMETHYLNITROSAMINE DEMETHYLASE; EPOXIDE HYDROLASE; ETHOXYRESORUFIN DEETHYLASE; GLUTATHIONE TRANSFERASE; OXIDOREDUCTASE; PHENACETIN O DEETHYLASE;

CHEMICAL MUTAGENESIS; DNA ADDUCT; ENZYME POLYMORPHISM; GENETIC RISK; GENOTOXICITY; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR; XENOBIOTIC METABOLISM;

EID: 0033795121     PISSN: 13835742     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5742(00)00051-X     Document Type: Article

References (108)

1. CEC (Commission of the European Communities), Indicators for assessing exposure and biological effects of genotoxic chemicals Consensus and technical reports, in: A. Aitio, G. Becking, A. Berlin, V. Foà, D. Kello, E. Krug, A. Léonard, G. Nordberg, (Eds.) EUR 11642 en. Brussels-Luxembourg, 1988, p. 191.
2. Hagmar L., Bonassi S., Stromberg U.et al. Cancer preventive value of cytogenetic markers used in occupational health surveillance programs a report from an ongoing study by the European study group on cytogenetic biomarkers and health. Mutat. Res. 405:1998;171-178.
3. Wong R.-H., Wang J.-D., Hsieh L.-L.et al. Effects on sister chromatid exchange frequency of aldehyde dehydrogenase 2 genotype and smoking in vinyl chloride workers. Mutat. Res. 420:1998;99-107.
4. Crab D.W., Edenberg H.J., Bosron W.F.et al. Genotypes for aldehyde dehydrogenase deficiency and alcohol sensitivity. J. Clin. Invest. 83:1989;14-16.
5. Nebert D.W. The Ah locus genetic differences in toxicity, cancer, mutation, and birth defects. CRC Crit. Rev. Toxicol. 20:1989;153-174.
6. Garte S. The role of ethnicity in cancer susceptibility gene polymorphisms the example of CYP1A1. Carcinogenesis. 19:1997;1329-1332.
7. Sinha R., Rothman N., Brown E.D.et al. Pan-fried meat containing high levels of heterocyclic aromatic amines but low levels of polycyclic aromatic hydrocarbons induces cytochrome P451A2 activity in human. Cancer Res. 54:1994;6154-6159.
8. Farin F.M., Pohlman T.H., Omiecinski C.J. Expression of cytochrome P450s and microsomal epoxide hydrolase in primary cultures of human umbilical vein endothelial cells. Toxicol. Appl. Pharmacol. 124:1994;1-9.
9. Nakajima M., Tsuyoshi Y., Mizutani M.et al. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene effect on the CYP1A2 inducibility in humans. J. Biochem. 125:1999;803-808.
10. Koop D.R. Oxidative and reductive metabolism by cytochrome P450 2E1. FASEB J. 6:1992;724-730.
11. Kim S.G., Novak R.F. Role of P450 IIE1 in the metabolism 3-hydroxypyridine, a costituent of tobacco smoke redox cycling and DNA strand scission by the metabolite 2,5-dihydroxypyridine. Cancer Res. 50:1990;5333-5339.
12. McBride O.W., Umeno M., Gelboin H.V., Gonzales F.J. A Taq I polymorphism in the human P450 IIE1 gene on chromosome 10 (CYP2E). Nucleic Acids Res. 15:1987;10071.
13. S. Garte, F. Crosti, Chapter 2. A nomenclature system for metabolic gene polymorphisms, in: W. Ryder (Ed.), Metabolic Polymorphism and Susceptibility to Cancer vol. 148 IARC Scientific Publication, Lyon, France, 1999, pp. 5-12.
14. Chang T.K.H., Yu L., Goldstein J.A., Waxman D.J. Identification of the polymorphically expressed CYP2C19 and the wild-type CYP2C9-ILE359 allele as low-K-m catalysts of cyclophosphamide and ifosfamide activation. Pharmacogenetics. 7:1997;211-221.
15. Nebert D.W., McKinnon R.A., Puga A. Human drug metabolizing enzime polymorphisms effects on risk of toxicity and cancer DNA. Cell Biol. 15:1996;273-280.
16. Sachse C., Brokmoller J., Bauer S.et al. Cytochrome P450 2D6 variants in a Caucasian population allele frequencies and phenotypic consequences. Am. J. Hum. Genet. 60:1997;284-295.
17. Hassett C., Aicher L., Sidhu J.S., Omiecinski C.J. Human microsomal epoxide hydrolase genetic polymorphism and functional expression in vitro of amino acid variants. Hum. Mol. Genet. 3:1994;421-428.
18. Seidegard J., Ekstrom G. The role of human glutathione transferases and epoxide hydrolase in the metabolism of xenobiotics. Environ. Health Perspect. 105:1997;791-799.
19. Hayes J.D., Pulford D.J. The glutathione S-transferase supergene Family Regulation of GST and the contribution of the isoenzymes to cancer chemoprotection and drug resistance. Crit. Rev. Biochem. Mol. Biol. 30:1995;445-600.
20. Board P.G., Weber G.C., Coggan M. Isolation of a c DNA clone and localisation of the human glutathione s-transferase 3 gene to chromosome bands 11q3 and 12q13-14. Ann. Hum. Genet. 53:1989;205-213.
21. Ryberg D., Skaug V., Hewer A.et al. Genotypes of glutathione transferase M1 and P1 and their significance for lung DNA adduct levels and cancer risk. Carcinogenesis. 18:1997;1285-1289.
22. Harries L.W., Stubbins M.J., Forman D.et al. Identification of genetic polymorphisms at the glutathione s-transferase Pi locus and association with susceptibility to bladder, testicular and prostate cancer. Carcinogenesis. 18:1997;641-644.
23. Thier R., Pemble S.E., Kramer H.et al. Human glutathione S-trasferase T1 enhances mutagenicity of 1,2-dibromoethane, dibromomethane and 1,2,3,4-diepoxybutane in Salmonella typhimurium. Carcinogenesis. 17:1996;163-166.
24. Pelin K., Hirvonen A., Norppa H. Influence of erythrocyte glutathione S-transferase T1 on sister chromatid exchange induced by diepoxybutane in cultured human lymphocytes. Mutagenesis. 11:1996;213-215.
25. Hein D.W., Doll M.A., Rustan T.D.et al. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis. 14:1993;. 1633-163.
26. Grant D.M. Molecular genetics of the N-acetyltransferases. Pharmacogenetics. 3:1993;45-50.
27. Evans D.A.P. N-acetyltransferase. Pharmacol. Ter. 42:1989;157-234.
28. Blum M., Demiere A., Grant D.M. Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc. Natl. Acad. Sci. U. S. A. 88:1991;5237-5241.
29. Meyer U.A., Zanger U.M. Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu. Rev. Pharmacol. Toxicol. 37:1997;269-296.
30. Kadlubar F.F., Butler M.A., Kaderlik K.R.et al. Polymorphism of aromatic amine metabolism in humans relevance for human carcinogenesis. Environ. Health Perspect. 98:1992;69-74.
31. Rothman N., Smith M.T., Hayes R.B.et al. Benzene poisoning, a risk factor for haematological malignancy is associated with the NQO1 609C→T mutation and rapid fractional excretion of chloroxazone. Cancer Res. 57:1997;2839-2842.
32. Moran J.L., Siege L.D., Ross D. A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc. Natl. Acad. Sci. U. S. A. 96:1999;8150-8155.
33. Hubert R., Adler D.A., Disteche C.M.et al. The molecular basis of the human serum paraoxonase activity polymorphism. Nat. Genet. 3:1993;73-76.
34. Smitz C., Lindpaintner K. Two specific and simple methods for genotyping of the paraoxonase/arylesterase A/B polymorphism. Genet. Anal. 1:1997;11-49.
35. Vos R.M., van Welie R.T., Peters W.H.et al. Genetic deficiency of human class mu glutathione S-transferase isoenzymes in relation to the urinary excretion of the mercapturic acids of Z- and E-1,3-dichloropropene. Arch. Toxicol. 65:1991;95-99.
36. Hayes R.B., Zhang L., Yin S.et al. Genotoxic markers among butadiene polymer workers in China. Carcinogenesis. 21:2000;55-62.
37. Riffelmann M., Mueller G., Schmieding W.et al. Biomonitoring of urinary aromatic amines and arylamine hemoglobin adducts in exposed workers and nonexposed control persons. Int. Arch. Occup. Environ. Health. 68:1995;36-43.
38. Rothman N., Bhatnagar V.K., Hayes R.B.et al. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc. Natl. Acad. Sci. U. S. A. 93:1996;5084-5089.
39. Koizumi A., Nomiyama T., Tsukada M.et al. Evidence on N-acetyltransferase allele-associated metabolism of hydrazine in Japanese workers. J. Occup. Environ. Med. 40:1998;217-222.
40. Binkova B., Lewtas J., Mìskova I.et al. Biomarker studies in northern Bohemia. Environ. Health Perspect. 104(Suppl. 3):1996;591-597.
41. Costa D.J., Slott V., Binkova B.et al. Influence of GSTM1 and NAT2 genotypes on the relationship between personal exposure to PAHs and biomarkers of internal dose. Biomarkers. 3:1998;411-424.
42. Motykiewicz G., Michalska J., Pendzich J.et al. A molecular epidemiology study in women from Upper Silesia, Poland. Toxicol. Lett. 96:1998;195-202.
43. Hemminki K., Dickey C., Karlsson S.et al. Aromatic DNA adducts in foundry workers in relation to exposure, life style and CYP1A1 and glutathione transferase M1 genotype. Carcinogenesis. 18:1997;345-350.
44. Merlo F., Andreassen A., Weston A.et al. Urinary excretion of 1-hydroxypyrene as a marker for exposure to urban air levels of polycyclic aromatic hydrocarbons. Cancer Epidemiol., Biomarkers. 7:1998;147-155.
45. Ovrebo S., Ryberg D., Haugen A., Leira H.L. Glutathione S-transferase M1 and P1 genotypes and urinary excretion of 1-hydroxypyrene in coke oven workers. Sci. Total Environ. 220:1998;25-31.
46. Poirier M.C., Weston A., Schoket B.et al. Biomonitoring of United States Army soldiers serving in Kuwait in 1991. Cancer Epidemiol., Biomarkers. 7:1998;545-551.
47. Pavanello S., Gabbani G., Mastrangelo G.et al. Influence of GSTM1 genotypes on anti-BPDE-DNA adduct levels in mononuclear white blood cells of humans exposed to PAHs. Int. Arch. Occup. Environ. Health. 72:1999;238-246.
48. Wu M.T., Huang S.L., Ho C.K.et al. Cytochrome P450 1A1 MspI polymorphism and urinary 1-hydroxypyrene concentrations in coke-oven workers. Cancer Epidemiol., Biomarkers. 7:1998;823-829.
49. Hong Y.C., Leem J.H., Park H.S.et al. Variations in urinary 1-hydroxypyrene glucuronide in relation to smoking and the modification effects of GSTM1 and GSTT1. Toxicol. Lett. 108:1999;217-223.
50. Yang M., Koga M., Katoh T., Kawamoto T.A. Study for the proper application of urinary naphthols. New biomarkers for airborne polycyclic aromatic hydrocarbons. Arch. Environ. Contam. Toxicol. 36:1999;99-108.
51. Bergamaschi E., Brustolin A., De Palma G.et al. Biomarkers of dose and susceptibility in cyclists exposed to monoaromatic hydrocarbons. Toxicol. Lett. 108:1999;241-247.
52. Rossi A.M., Guarnieri C., Rovesti S.et al. Genetic polymorphisms influence variability in benzene metabolism in humans. Pharmacogenetics. 9:1999;445-451.
53. Sinués B., Pérez J., Bernal M.L.et al. Urinary mutagenicity and N-acetylation phenotype in textile industry workers exposed to arylamines. Cancer Res. 52:1992;4885-4889.
54. Gabbani G., Hou S.M., Nardini B.et al. GSTM1 and NAT2 genotypes and urinary mutagens in coke oven workers. Carcinogenesis. 17:1996;1677-1681.
55. Gabbani G., Pavanello S., Nardini B.et al. Influence of metabolic genotype GSTM1 on levels of urinary mutagens in patients treated topically with coal tar. Mutat. Res. 440:1999;27-33.
56. Santella R.M., Perera F.P., Young T.L.et al. Polycyclic aromatic hydrocarbon-DNA and protein adducts in coal tar treated patients and controls and their relationship to glutathione S-transferase genotype. Mutat. Res. 334:1995;117-124.
57. Autrup H., Daneshvar B., Dragsted L.O.et al. Biomarkers for exposure to ambient air pollution - comparison of carcinogen-DNA adduct levels with other exposure markers and markers for oxidative stress. Environ. Health Perspect. 107:1999;233-238.
58. Nielsen P.S., Okkels H., Sigsgaard T.et al. Exposure to urban and rural air pollution DNA and protein adducts and effect of glutathione-S-transferase genotype on adduct levels. Int. Arch. Occup. Environ. Health. 68:1996;170-176.
59. Zwirner-Baier I., Neumann H.G. Biomonitoring of aromatic amines V acetylation and deacetylation in the metabolic activation of aromatic amines as determined by haemoglobin binding. Arch. Toxicol. 72:1998;499-504.
60. Muller M., Kramer A., Angerer J., Hallier E. Ethylene oxide-protein adduct formation in humans influence of glutathione-S-transferase polymorphisms. Int. Arch. Occup. Environ. Health. 71:1998;499-502.
61. Vollmer D.M., Thier R., Bolt H.M. Determination of the ethylene oxide adduct S-(2-hydroxyethyl)cysteine by a fluorometric HPLC method in albumin and globin from human blood. Fresenius' J. Anal. Chem. 362:1998;324-328.
62. Sorsa M., Ostermangolkar S., Peltonen K.et al. Assessment of exposure to butadiene in the process industry. Toxicology. 113:1996;77-83.
63. Thier R., Lewalter J., Kempkes M.et al. Haemoglobin adducts of acrylonitrile and ethylene oxide in acrylonitrile workers, dependent on polymorphisms of the glutathione trasferases GSTT1 and GSTM1. Arch. Toxicol. 73:1999;197-202.
64. Takeshita T., Kawai T., Morimoto K. Elevated levels of haemoglobin-associated acetaldehyde related to alcohol drinking in atypical genotype of low K-m aldehyde dehydrogenase. Cancer Res. 57:1997;1241-1243.
65. Garnier R., Rambourg S.M., Muller A., Hallier E. Glutathione transferase activity and formation of macromolecular adducts in two cases of acute methyl bromide poisoning. Occup. Environ. Med. 53:1996;211-215.
66. Hallier E., Langhof T., Dannappel D.et al. Polymorphism of glutathione conjugation of methyl bromide, ethylene oxide and dichloromethane in human blood influence on the induction of sister chromatid exchanges (SCEs) in lymphocytes. Arch. Toxicol. 67:1993;173-178.
67. Sram R.J., Benes I., Binkova B.et al. Teplice program - the impact of air pollution on human health. Environ. Health Perspect. 104:1996;699-714.
68. Perera F.P., Jedrychowski W., Rauh V., Whyatt R.M. Molecular epidemiologic research on the effects of environmental pollutants on the fetus. Environ. Health Perspect. 107:1999;451-460.
69. Nielsen P.S., de Pater N., Okkels H., Autrup H. Environmental air pollution and DNA adducts in Copenhagen bus drivers - effect of GSMT1 and NAT2 genotypes on adduct levels. Carcinogenesis. 17:1996;1021-1027.
70. 32P-postlabelling. Mutat. Res. 416:1998;67-84.
71. Topinka J., Binkova B., Mrackova G. DNA adducts in human placenta as related to air pollution and to GSTM1 genotype. Mutat. Res. 390:1997;59-68.
72. Butkiewicz D., Grzybowska E., Hemminki K.et al. Modulation of DNA adduct levels in human mononuclear white blood cells and granulocytes by CYP1A1, CYP2D6 and GSTM1 genetic polymorphisms. Mutat. Res. 415:1998;97-108.
73. Ichiba M., Hagmar L., Rannug A.et al. Aromatic DNA adducts, micronuclei and genetic polymorphism for CYP1A1 and GSTM1 in chimney sweeps. Carcinogenesis. 15:1994;1347-1352.
74. Hou S.M., Lambert B., Hemminki K. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis. 16:1995;1913-1917.
75. Rojas M., Alexandrov K., Cascorbi I.et al. High benzo[a]pyrene diol-epoxide DNA adduct levels in lung and blood cells from individuals with combined CYP1A1 MspI/MspI-GSTM1*0/*0 genotypes. Pharmacogenetics. 8:1998;109-118.
76. Brescia G., Celotti L., Clonfero E.et al. The influence of cytochrome P450 1A1 and glutathione S-transferase M1 genotypes on biomarker levels in coke-oven workers. Arch. Toxicol. 73:1999;431-439.
77. Viezzer C., Norppa H., Clonfero E.et al. Influence of GSTM1, GSTT1, GSTP1, and EPHX gene polymorphisms on DNA adduct level and HPRT mutant frequency in coke-oven workers. Mutat. Res. 431:1999;259-269.
78. Sram R.J., Binkova B., Rossner P.et al. Adverse reproductive outcomes from exposure to environmental mutagens. Mutat. Res. 428:1999;203-215.
79. Whyatt R.M., Bell D.A., Jedrychowski W.et al. Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis. 19:1998;1389-1392.
80. Whyatt R.M., Santella R.M., Jedrychowski W.et al. Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ. Health Perspect. 106(Suppl. 3):1998;821-826.
81. Nakajima M., Takeuchi T., Takeshita T., Morimoto K. 8-hydroxydeoxyguanosine in human leucocyte DNA and daily health practice factors effects of individual alcohol sensitivity. Environ. Health Perspect. 104:1996;1336-1338.
82. Poulsen H.E., Loft S., Prieme H.et al. Oxidative DNA damage in vivo relationship to age, plasma antioxidant, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Radical Res. 29:1998;565-571.
83. Loft S., Poulsen H.E., Vistisen K., Knudsen L.E. Increased urinary excretion of 8-OH-2′-deoxyguanosine, a biomarker of oxidative DNA damage, in urban bus drivers. Mutat. Res. 441:1999;11-19.
84. Carstensen U., Hou S.M., Alexandrie A.K.et al. Influence of genetic polymorphisms of biotransformation enzymes on gene mutations, strand breaks of deoxyribonucleic acid, and micronuclei in mononuclear blood cells and urinary 8-hydroxydeoxyguanosine in potroom workers exposed to polyaromatic hydrocarbons. Scand. J. Work, Environ. Health. 25:1999;351-360.
85. Norppa H., Hirvonen A., Jarventaus H.et al. Role of GSTT1 and GSTM1 genotypes in determining individual sensitivity to sister chromatid exchange induction by diepoxybutane in cultured human lymphocytes. Carcinogenesis. 16:1995;1261-1264.
86. Wiencke J.K., Pemble S., Ketterer B., Kelsey K.T. Gene deletion of glutathione S-transferase θ correlation with induced genetic damage and potential role in endogenous mutagenesis. Cancer Epidemiol., Biomarkers. 4:1995;253-259.
87. Ollikainen T., Hirvonen A., Norppa H. Influence of GSTT1 genotype on sister chromatid exchange induction by styrene-7,8-oxide in cultured human lymphocytes. Environ. Mol. Mutagen. 31:1998;311-315.
88. Bernardini S., Pelin K., Peltonen K.et al. Induction of sister chromatid exchanges by 3,4-epoxybutane-1,2-diol in cultured human lymphocytes of different GSTT1 and GSTM1 genotypes. Mutat. Res. 36:1996;121-127.
89. Kelsey K.T., Wienke J.K., Ward J.et al. Sister chromatid exchanges, glutathione S-transferase θ deletion and cytogenetic sensitivity to diepoxybutane in lymphocytes from butadiene monomer production workers. Mutat. Res. 335:1995;267-273.
90. Sram R.J., Rossner P., Peltonen K.et al. Chromosomal aberrations, sister-chromatid exchanges, cells with high frequency of SCEs, micronuclei and comet assay parameters in 1,3-butadiene-exposed workers. Mutat. Res. 419:1998;145-154.
91. Kalina I., Brezani P., Gajdosova D.et al. Cytogenetic monitoring in coke oven workers. Mutat. Res. 417:1998;9-17.
92. Xu X.P., Wiencke J.K., Niu T.H.et al. Benzene exposure, glutathione S-transferase θ homozygous deletion, and sister chromatid exchanges. Am. J. Ind. Med. 33:1998;157-163.
93. Morimoto K., Takeshita T. Low K-m aldehyde dehydrogenase (ALDH2) polymorphism, alcohol-drinking behavior and chromosome alterations in peripheral lymphocytes. Environ. Health Perspect. 104:1996;563-567.
94. Cheng T.J., Hwang S.J., Kuo H.V.et al. Exposure to epichlorohydrin and dimethylformamide, glutathione S-transferase and sister chromatid exchange frequencies in peripheral lymphocytes. Arch. Toxicol. 73:1999;282-287.
95. Wu F.Y., Tsai F.J., Kuo H.W.et al. Cytogenetic study of workers exposed to chromium compounds. Mutat. Res. 464:2000;289-296.
96. Scarpato R., Migliore L., Hirvonen A.et al. Cytogenetic monitoring of occupational exposure to pesticides Characterization of GSTM1, GSTT1, and NAT2 genotypes. Environ. Mol. Mutagen. 27:1996;263-269.
97. Knudsen L.E., Norppa H., Gamborg M.O.et al. Chromosomal aberrations in humans induced by urban air pollution Influence of DNA repair and polymorphisms of glutathione S-transferase M1 and N-acetyltransferase 2. Cancer Epidemiol., Biomarkers. 8:1999;303-310.
98. Au W.W., Sierra-Torres C.H., Cajas-Salazar N.et al. Cytogenetic effects from exposure to mixed pesticides and the influence from genetic susceptibility. Environ. Health Perspect. 107:1999;501-505.
99. Oberheitmann B., Schafer J., Dally H.et al. The chromosome-based challenge assay using fluorescence in situ hybridization a possible test for increased cancer susceptibility. Mutat. Res. 428:1999;157-164.
100. Carstensen U., Alexandrie A.K., Hoegstedt B.et al. B- and T-lynphocyte micronuclei in chimney sweeps with respect to genetic polymorphism for CYP1A1 and GST1 (class Mu). Mutat. Res. 289:1993;187-195.
101. Lucero L., Pastor S., Suarez S.et al. Cytogenetic biomonitoring of Spanish greenhouse workers exposed to pesticides micronuclei analysis in peripheral blood lymphocytes and buccal epithelial cells. Mutat. Res. 464:2000;255-262.
102. Falck G.C.M., Hirvonen A., Scarpato R.et al. Micronuclei in blood lymphocytes and genetic polymorphism for GSTM1, GSTT1 and NAT2 in pesticide-exposed greenhouse workers. Mutat. Res. 441:1999;225-237.
103. Rossi C., Buschini A., Poli P.et al. Individual susceptibility and DNA damage assessed by the COMET assay in workers occupationally exposed to styrene. VII Annual Congress of the Italian Environmental Mutagen Society, Cortona October 6-8. 1999;27.
104. Sram R.J., Podrazilova K., Dejmek J.et al. Single cell gel electrophoresis assay sensitivity of peripheral white blood cells in human population studies. Mutagenesis. 13:1998;99-103.
105. Anderson D., Yu T., Hambly R.J., Mendy M., Wild C.P. Aflatoxin exposure and DNA damage in the comet assay in individuals from the Gambia, West Africa, Teratog. Carcinog. Mutagen. 19:1999;147-155.
106. Pitarque M., Vaglenov A., Nosko M.et al. Evaluation of DNA damage by the Comet assay in shoe workers exposed to toluene and other organic solvents. Mutat. Res. 441:1999;115-127.
107. Au W.W., Cajas-Salazar N., Salama S. Factors contributing to discrepancies in population monitoring studies. Mutat. Res. 400:1998;467-478.
108. Vineis P., Martone T. Genetic environmental interactions and low-level exposure to carcinogens. Epidemiology. 6:1995;455-457.